La Renon Healthcare
PrivateLast Round
Secondary
Nov 21, 2025
Est. Valuation
$1.2B
Total Funding Raised
$46M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
La Renon Healthcare operates in Healthcare & Life Sciences and is based in Ahmedabad. Its latest recorded funding round was a Series B round in January 2021.
La Renon Healthcare is a pharmaceutical company that develops and manufactures branded chronic-therapy pharmaceutical formulations across various therapeutic segments including nephrology, neurology, critical care, and cardio-metabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
La Renon Healthcare Comparables
Compare La Renon Healthcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alniche Lifesciences Private Limited | 84% | |
| Eris Lifesciences Limited | 83% | |
| Zuventus Healthcare Limited | 80% |
For institutional investors. Book with your work email.
La Renon Healthcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Secondary | Nov 21, 2025 | ||||
| Secondary | Apr 16, 2024 | ||||
| Secondary | Feb 4, 2024 | ||||
| M&A | Jan 20, 2022 | ||||
| Series B | Jan 11, 2021 | ||||
Series A | Jun 12, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
La Renon Healthcare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| White Oak Capital Management | Secondary |
| ChrysCapital | Secondary |
| A91 Partners | Series B |
| Ashoka WhiteOak Capital | Secondary |
| Peak XV Partners | Series A |
| Commelina Ltd. | Secondary |
| White Oak | Secondary |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
Ranked among the top 50 pharmaceutical companies in India.
- Jun 5, 2026
Ranked among the top 25 pharma companies in India.
For institutional investors. Book with your work email.
La Renon Healthcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about La Renon Healthcare's valuation, stock price, and market status.
Is La Renon Healthcare a public or private company?
La Renon Healthcare is a private company.
What is the current stock price of La Renon Healthcare?
La Renon Healthcare is a private company, so its shares have no public market price. Caplight tracks La Renon Healthcare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is La Renon Healthcare worth (valuation)?
La Renon Healthcare's valuation is estimated at $1.2B based on funding round data.
Can I buy La Renon Healthcare stock?
La Renon Healthcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was La Renon Healthcare's last funding round?
La Renon Healthcare's most recent funding round was Secondary on November 21, 2025.
Who are the main investors in La Renon Healthcare?
Key investors in La Renon Healthcare include A91 Partners, Commelina Ltd., Avendus Capital, Sequoia Capital.
Will La Renon Healthcare IPO soon?
No public IPO plans have been announced for La Renon Healthcare.
How can I track La Renon Healthcare secondary market activity?
Caplight tracks bids, offers, and trades in La Renon Healthcare's shares on secondary markets.